Inga Urbonaviciute

Inga Urbonaviciute serves as a Specialist Physician (Speciallæge) at Aalborg University Hospital within the Faculty of Medicine's Department of Neurology. Her clinical-academic role bridges patient care with rigorous research in neurological disorders, particularly focusing on multiple sclerosis therapeutics and outcomes.

Her research interests center on multiple sclerosis pharmacotherapy, with deep expertise in teriflunomide and ocrelizumab treatments. Key investigation areas include prognostic factors for disease activity, extended interval dosing protocols, and comparative drug safety profiles, particularly regarding hypertension risks. This work leverages Denmark's national healthcare registry for robust cohort analyses.

Analysis of her four publications (2023-2025) reveals consistent focus on real-world treatment outcomes in newly diagnosed multiple sclerosis patients. Her studies examine demographic influences (age/sex), long-term disease trajectories, and comparative efficacy of disease-modifying therapies through nationwide Danish cohort methodologies.

As a contributing member of the DMSG study group, she collaborates extensively with leading Danish neurology researchers including Sellebjerg, Illes, and Stilund. Her work demonstrates strong institutional integration within Denmark's national multiple sclerosis research infrastructure, though specific laboratory or team structures aren't detailed in available materials.